Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,115 | 21 | 76.1% |
| Honoraria | $350.00 | 1 | 23.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biofrontera Inc. | $457.32 | 2 | $0 (2018) |
| Galderma Laboratories, L.P. | $331.88 | 5 | $0 (2024) |
| LEO Pharma Inc. | $127.10 | 3 | $0 (2024) |
| UCB, Inc. | $113.84 | 2 | $0 (2024) |
| Incyte Corporation | $102.94 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $92.59 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $92.41 | 1 | $0 (2023) |
| GENZYME CORPORATION | $91.19 | 1 | $0 (2024) |
| AbbVie, Inc. | $20.78 | 1 | $0 (2019) |
| ConvaTec Inc. | $18.47 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $422.81 | 6 | Galderma Laboratories, L.P. ($125.00) |
| 2023 | $213.82 | 3 | Incyte Corporation ($102.94) |
| 2022 | $50.86 | 1 | LEO Pharma Inc. ($50.86) |
| 2021 | $16.90 | 1 | Lilly USA, LLC ($16.90) |
| 2020 | $271.47 | 7 | Galderma Laboratories, L.P. ($206.88) |
| 2019 | $20.78 | 1 | AbbVie, Inc. ($20.78) |
| 2018 | $468.78 | 3 | Biofrontera Inc. ($457.32) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $102.38 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $63.24 | General |
| Category: DERMATOLOGY | ||||||
| 02/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $91.19 | General |
| Category: Immunology | ||||||
| 12/15/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 11/01/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $92.41 | General |
| 09/07/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $102.94 | General |
| Category: Dermatology | ||||||
| 12/01/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $50.86 | General |
| Category: DERMATOLOGY | ||||||
| 04/16/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Immunology | ||||||
| 11/12/2020 | Galderma Laboratories, L.P. | ORACEA (Drug) | Food and Beverage | In-kind items and services | $114.08 | General |
| Category: ROSACEA | ||||||
| 10/23/2020 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/17/2020 | Galderma Laboratories, L.P. | EPIDUO FORTE (Drug), AKLIEF | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: ACNE | ||||||
| 09/01/2020 | Galderma Laboratories, L.P. | EPIDUO FORTE (Drug), AKLIEF | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: ACNE | ||||||
| 08/25/2020 | Galderma Laboratories, L.P. | ORACEA (Drug), EPIDUO FORTE, AKLIEF | Food and Beverage | In-kind items and services | $84.16 | General |
| Category: ROSACEA | ||||||
| 08/25/2020 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: DERMATOLOGY | ||||||
| 01/11/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Immunology | ||||||
| 11/30/2018 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Honoraria | Cash or cash equivalent | $350.00 | General |
| Category: Dermatology | ||||||
| 11/08/2018 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Food and Beverage | Cash or cash equivalent | $107.32 | General |
| Category: Dermatology | ||||||
| 09/10/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,785 | 3,413 | $1.6M | $685,911 |
| 2022 | 33 | 2,690 | 3,302 | $1.6M | $760,864 |
| 2021 | 33 | 2,413 | 3,112 | $1.5M | $745,419 |
| 2020 | 15 | 679 | 813 | $615,574 | $301,691 |
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 583 | 750 | $600,750 | $278,286 | 46.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 241 | 320 | $143,680 | $89,231 | 62.1% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 58 | 62 | $88,102 | $41,362 | 46.9% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 63 | 64 | $69,760 | $32,731 | 46.9% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 66 | 75 | $50,550 | $29,123 | 57.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 166 | 174 | $116,406 | $29,034 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 411 | 501 | $53,548 | $27,486 | 51.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 133 | 148 | $62,308 | $24,509 | 39.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 128 | 134 | $56,012 | $15,072 | 26.9% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 21 | 21 | $29,736 | $13,665 | 46.0% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 21 | 21 | $27,657 | $13,140 | 47.5% |
| 14021 | Repair of wound of scalp, arms, or legs by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 17 | 17 | $20,723 | $10,149 | 49.0% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 46 | 48 | $34,128 | $8,568 | 25.1% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 66 | 69 | $28,359 | $8,036 | 28.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 138 | 167 | $22,712 | $7,857 | 34.6% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 15 | 15 | $16,005 | $7,300 | 45.6% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 24 | 27 | $11,097 | $7,242 | 65.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 42 | 43 | $25,757 | $6,860 | 26.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 58 | 70 | $24,150 | $5,872 | 24.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 53 | 73 | $17,885 | $5,576 | 31.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 33 | 36 | $14,220 | $3,741 | 26.3% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2023 | 49 | 54 | $7,668 | $3,680 | 48.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 100 | 115 | $10,465 | $3,352 | 32.0% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 20 | 20 | $7,360 | $2,606 | 35.4% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 12 | 12 | $5,316 | $2,064 | 38.8% |
About Dr. Bryan Baillis, M.D
Dr. Bryan Baillis, M.D is a MOHS-Micrographic Surgery healthcare provider based in Medina, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2014. The National Provider Identifier (NPI) number assigned to this provider is 1699193508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Baillis, M.D has received a total of $1,465 in payments from pharmaceutical and medical device companies, with $422.81 received in 2024. These payments were reported across 22 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,115).
As a Medicare-enrolled provider, Baillis has provided services to 8,567 Medicare beneficiaries, totaling 10,640 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Student in an Organized Health Care Education/Training Program, Dermatology
- Location Medina, OH
- Active Since 03/29/2014
- Last Updated 10/31/2020
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1699193508
Products in Payments
- Ameluz (Drug) $457.32
- ORACEA (Drug) $198.24
- DUPIXENT (Biological) $146.53
- ADBRY (Biological) $114.10
- OPZELURA (Drug) $102.94
- Bimzelx (Biological) $102.38
- LIBTAYO (Biological) $37.25
- Humira (Biological) $20.78
- INNOVAMATRIX AC (Device) $18.47
- TALTZ (Drug) $16.90
- ENSTILAR (Drug) $13.00
- Cimzia (Drug) $11.46
- EPIDUO FORTE (Drug) $8.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.